Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 3

2(40.0%)

5Total

N/A(3)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT02480621Phase 3Completed

Liposomal Bupivacaine With Bupivacaine in Ankle Fracture Open Reduction Internal Fixation (ORIF)

Role: lead

NCT00746759Completed

Airway Epithelium Gene Expression: AEGIS IDE

Role: collaborator

NCT01605292Not ApplicableCompleted

Radial Artery Access With Ultrasound Trial

Role: collaborator

NCT00374348Not ApplicableCompleted

Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)

Role: lead

NCT00856596Phase 3Unknown

Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and Females

Role: lead

NCT00740766Not ApplicableCompleted

Perinatal Outcomes in Nutritionally Monitored Obese Pregnant Women

Role: lead

All 6 trials loaded